Cargando…
P06 Waldenström macroglobulinemia – beware the label of primary Raynaud’s Phenomenon
CASE REPORT - INTRODUCTION: Waldenström’s macroglobulinemia (WM) is a rare haematological malignancy accounting for 2% of blood cancers. It is characterised by an immunoglobulin M (IgM)-associated lymphoplasmacytic lymphoma and usually follows an indolent disease course. Most patients present with n...
Autores principales: | Gor, Shivani, Waller, Rosemary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832403/ http://dx.doi.org/10.1093/rap/rkab068.005 |
Ejemplares similares
-
Raynaud's Phenomenon: Beware of Cancers!
por: Aqodad, Zahida, et al.
Publicado: (2021) -
Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia
por: Amalnath, S. D., et al.
Publicado: (2013) -
Waldenstrom’s Macroglobulinemia: An Update
por: Mazzucchelli, Maddalena, et al.
Publicado: (2018) -
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022) -
P1145: OUTCOMES AND TREATMENT PATTERNS AFTER FIRST RELAPSE IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA
por: Tawfiq, R., et al.
Publicado: (2022)